39.05
Crispr Therapeutics Ag (CRSP) 最新ニュース
CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue? - Yahoo
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Raised by Green Alpha Advisors LLC - MarketBeat
Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline? - Yahoo Finance
Promising Growth and Diversification Drive Buy Rating for Crispr Therapeutics AG - TipRanks
Can CRISPR Build On Casgevy's Success With Its In Vivo Pipeline? - Barchart.com
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Voloridge Investment Management LLC - MarketBeat
The Best Stocks to Invest $1,000 in Right Now - The Motley Fool
Capital Market Strategies LLC Buys 9,652 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Q2 EPS Forecast for CRISPR Therapeutics Increased by Analyst - MarketBeat
Insider Selling: CRISPR Therapeutics AG (NASDAQ:CRSP) Insider Sells 3,932 Shares of Stock - MarketBeat
Cas9 Technology Market Projected to Hit $30.4 Billion at a 19.81% CAGR by 2032 - industrytoday.co.uk
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip - Yahoo Finance
Trading (CRSP) With Integrated Risk Controls - news.stocktradersdaily.com
Top 5 CRISPR Companies To Invest In (June 2025) - Securities.io
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Zacks Research Has Positive Outlook for CRSP Q2 Earnings - Defense World
Two Sigma Advisers LP Buys 28,400 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.75 Consensus Target Price from Analysts - MarketBeat
ARK Investment Expands Stake in Crispr Therapeutics (CRSP) | CRS - GuruFocus
ARK Investment Expands Stake in Crispr Therapeutics (CRSP) | CRSP Stock News - GuruFocus
Cathie Wood’s ARK Investment buys 294K shares of Crispr Therapeutics today - TipRanks
ARK Investment Increases Stake in Crispr Therapeutics (CRSP) | CRSP Stock News - GuruFocus
CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Two Sigma Investments LP Grows Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Crispr Therapeutics, Clover Health among healthcare stocks to join Russell 3000; INO, SAVA to exit - Seeking Alpha
CRISPR and Cas Genes Market Set to Witness Significant Growth - openPR.com
Cathie Wood’s ARK Investment buys 262K shares of Crispr Therapeutics today - TipRanks
Ameriprise Financial Inc. Acquires 18,412 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Westwood Holdings Group Inc. Raises Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics' (CRSP) "Market Outperform" Rating Reiterated at JMP Securities - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Earns "Buy" Rating from HC Wainwright - MarketBeat
CRISPR Therapeutics’ SWOT analysis: gene-editing pioneer’s stock faces pivotal year - Investing.com Nigeria
Q2 EPS Estimate for CRISPR Therapeutics Decreased by Analyst - MarketBeat
Rafferty Asset Management LLC Lowers Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Northern Trust Corp Has $10.12 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Cetera Investment Advisers Reduces Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - Defense World
Q2 EPS Estimate for CRISPR Therapeutics Lowered by Analyst - Defense World
Transcript : CRISPR Therapeutics AG Presents at H.C. Wainwright 3rd Annual BioConnect Investor Conference 2025, May-20-2025 04 - marketscreener.com
Transcript : CRISPR Therapeutics AG Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 10 - marketscreener.com
CRSP July 3rd Options Begin Trading - Nasdaq
大文字化:
|
ボリューム (24 時間):